MAGS Bundles the Magnificent Seven Into One Ticker, And That Concentration Cuts Both Ways

The Magnificent Seven question facing investors in 2026 is how to own these names. Roundhill Magnificent Seven ETF (NYSEARCA:MAGS | MAGS Price Prediction) answers with one ticker holding all seven mega caps at equal weight, rebalanced quarterly so no single name dominates. MAGS gathered roughly $4.7 billion in assets because retail investors wanted the basket without picking which AI winner mattered most. Whether you want exactly that is the harder question.

What equal weight actually buys you

You are supposed to get equal weight to each Magnificent 7 stock. Thus, the ETF’s composition has 7 near-equivalent chunks of Alphabet (NASDAQ:GOOG), Amazon (NASDAQ:AMZN), Apple (NASDAQ:AAPL), Meta (NASDAQ:META), Microsoft (NASDAQ:MSFT), NVIDIA (NASDAQ:NVDA), and Tesla (NASDAQ:TSLA). Equal weighting means the fund mechanically trims winners every quarter and tops up laggards. If NVDA rips 30% in a quarter, MAGS sells some down to restore a one-seventh slice. Market-cap-weighted funds do the opposite, letting winners compound.

Roundhill uses physical share holdings combined with total return swaps with Goldman Sachs and other counterparties to maintain Investment Company Act diversification compliance. The fund parks Treasury bills and the Roundhill Ultra Short Duration ETF as collateral against swap positions. Standard plumbing for this structure, but you own a contractual claim that tracks the stocks rather than always owning the shares themselves.

Does the basket actually deliver

Over the past year MAGS returned 33%. The Invesco QQQ (NASDAQ:QQQ) returned 37% over the same window while holding the Mag Seven plus 93 other Nasdaq names. The concentrated bet matched a more diversified fund, which tells you the Mag Seven did the work either way. Concentration cost roughly nothing in this stretch.

Under the hood the dispersion is wild, since not every Mag 7 stock performed the same. Some pulled ahead massively, like NVDA and GOOG, whereas others lagged behind. Equal weighting forced MAGS to keep adding to laggards through every quarterly rebalance. In a year where Alphabet did almost all the work, that mechanical trimming cost you upside a market-cap-weighted vehicle would have captured.

What you give up

Three real constraints sit inside this design.

1. Single-name concentration. Each holding is roughly 14% of the fund, so a regulatory shock to one name moves MAGS at the basket level with no offset from the other six. Equal weighting that limits one stock’s upside also guarantees full exposure to its downside.
2. Counterparty exposure. Total return swaps put Goldman Sachs and other dealers in the chain. Collateral protects you, but a counterparty failure creates disruption that a direct stockholder would never see.
3. Fee and tax drag. The 0.29% expense ratio runs roughly six times what Vanguard Mega Cap Growth ETF (NYSEARCA:MGK) charges at 0.05%. MGK returned 28% over the past year holding the same names market-cap weighted plus more. Swap-based ETFs can produce ordinary-income distributions in years when qualified dividends would have been more tax efficient.

Who this fits, who should skip

MAGS makes sense as a 5% to 15% satellite for investors who want clean Mag Seven exposure without managing seven positions and accept paying 0.29% for the convenience. It pairs reasonably with a broad index core rather than replacing one. If you already own an S&P 500 fund, you hold roughly 30% Mag Seven by weight, so MAGS doubles down rather than diversifies.

Skip MAGS if you want diversified growth, if swap-based structures bother you, or if you’d rather let market-cap weighting carry the strongest names higher without quarterly trimming. The fund’s design is honest about what it is. The next real Mag Seven drawdown will reveal whether equal-weighted exposure feels as good going down as it has going up.